Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Recovery from knee surgery GLP-1s might influence recovery from knee replacement surgery, suggests a new retrospective study published in the medical journal The Knee
raises IGF-1 and carries glucose-tolerance risk Compound Semaglutide (Wegovy) Class GLP-1 receptor agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
Lancet Diabetes Endocrinol 2025;13:674684
The detailed combination guide covers the evidence, risks, and monitoring requirements for dual therapy
Both routes are effective, but Maximus typically recommends subcutaneous injections
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
